InnoCare Pharma Limited (9969.HK)

HKD 6.1

(0.16%)

Total Liabilities Summary of InnoCare Pharma Limited

InnoCare Pharma Limited's latest annual total liabilities in 2023 was 2.73 Billion CNY , up 2.3% from previous year.
InnoCare Pharma Limited's latest quarterly total liabilities in 2024 Q2 was 2.73 Billion CNY , up 0.94% from previous quarter.
InnoCare Pharma Limited reported annual total liabilities of 2.67 Billion CNY in 2022, up 53.96% from previous year.
InnoCare Pharma Limited reported annual total liabilities of 1.73 Billion CNY in 2021, up 26.24% from previous year.
InnoCare Pharma Limited reported quarterly total liabilities of 2.71 Billion CNY for 2024 Q1, down -0.96% from previous quarter.
InnoCare Pharma Limited reported quarterly total liabilities of 2.64 Billion CNY for 2023 Q1, down -1.09% from previous quarter.

Annual Total Liabilities Chart of InnoCare Pharma Limited (2023 - 2017)

Historical Annual Total Liabilities of InnoCare Pharma Limited (2023 - 2017)

Year	Total Liabilities	Total Liabilities Growth
2023	2.73 Billion CNY	2.3%
2022	2.67 Billion CNY	53.96%
2021	1.73 Billion CNY	26.24%
2020	1.37 Billion CNY	-75.25%
2019	5.56 Billion CNY	83.04%
2018	3.03 Billion CNY	508.56%
2017	499.46 Million CNY	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	2.73 Billion CNY	0.94%
2024 Q1	2.71 Billion CNY	-0.96%
2023 Q1	2.64 Billion CNY	-1.09%
2023 FY	2.73 Billion CNY	2.3%
2023 Q3	2.65 Billion CNY	-1.06%
2023 Q2	2.68 Billion CNY	1.53%
2023 Q4	2.73 Billion CNY	2.96%
2022 Q4	2.67 Billion CNY	1.04%
2022 Q3	2.64 Billion CNY	24.93%
2022 Q2	2.12 Billion CNY	0.0%
2022 Q1	- CNY	-100.0%
2022 FY	2.67 Billion CNY	53.96%
2021 Q4	1.73 Billion CNY	0.0%
2021 FY	1.73 Billion CNY	26.24%
2021 Q1	1.47 Billion CNY	7.29%
2021 Q2	1.47 Billion CNY	0.0%
2020 Q4	1.37 Billion CNY	0.0%
2020 Q2	1.37 Billion CNY	0.0%
2020 Q1	1.37 Billion CNY	-75.24%
2020 FY	1.37 Billion CNY	-75.25%
2020 Q3	1.37 Billion CNY	-0.03%
2019 Q1	3.66 Billion CNY	20.6%
2019 FY	5.56 Billion CNY	83.04%
2019 Q3	4.13 Billion CNY	12.74%
2019 Q2	3.66 Billion CNY	0.0%
2019 Q4	5.56 Billion CNY	34.61%
2018 FY	3.03 Billion CNY	508.56%
2018 Q4	3.03 Billion CNY	0.0%
2017 FY	499.46 Million CNY	0.0%

Peer Total Liabilities Comparison of InnoCare Pharma Limited

Name	Total Liabilities	Total Liabilities Difference
Uni-Bio Science Group Limited	152.81 Million HKD	-1691.951%
CK Life Sciences Int'l., (Holdings) Inc.	7.05 Billion HKD	61.202%